Healthcare | Mergers & Acquisitions

Immucor Acquires BioArray Solutions

  • Immucor, Inc. is a leading supplier of diagnostic reagents and automated instrumentation to ensure the safety of blood transfusions
  • Immucor is publicly traded on NASDAQ under the symbol BLUD with a market value of over $2 billion
  • BioArray Solutions Ltd. has pioneered the development of advanced genotyping technology for blood transfusions
  • TM Capital assisted Immucor in negotiating and completing the acquisition of BioArray for $117 million in cash

See Press Release

Client Testimonial